Internal Medicine, Endocrinology, Diabetes, & Metabolism · Denver, CO
NPI
1891822839
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1375 E 20th Ave
Denver, CO, 80205
Phone (303) 338-4545
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,913
74 services
Medicare patients, 2024
11
Average age 62
Drug cost, 2024
$769K
2,888 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug John J Orrego prescribed most often to Medicare patients was Levothyroxine Sodium, with 472 prescriptions and refills. In total John J Orrego wrote 2,888 Medicare prescriptions that cost $769K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-14.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levothyroxine Sodium Generic | 472 | 1,380 | 144 | $8,456 |
| Methimazole Generic | 235 | 636 | 77 | $5,224 |
| Forteo Teriparatide | 231 | 231 | 34 | $315K |
| Ozempic Semaglutide | 155 | 157 | 25 | $116K |
| Insulin Glargine-Yfgn Generic | 140 | 314 | 48 | $17K |
| Testosterone Generic | 118 | 153 | 27 | $5,455 |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 110 | 216 | 42 | $2,329 |
| Humalog Insulin Lispro | 89 | 240 | 30 | $19K |
| Hydrocortisone Generic | 86 | 217 | 27 | $4,135 |
| Jardiance Empagliflozin | 82 | 209 | 24 | $42K |
| Alendronate Sodium Generic | 77 | 210 | 27 | $748 |
| Atorvastatin Calcium Generic | 76 | 199 | 22 | $835 |
| Humulin R Insulin Regular, Human | 69 | 168 | 23 | $8,725 |
| Prednisone Generic | 64 | 147 | 19 | $547 |
| Metformin Hcl Generic | 64 | 178 | 23 | $695 |
Brand drugs: 980 claims; generic drugs: 1,660 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to John J Orrego were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.